Cancer

Our sun safety messaging tours the UK with the NIVEA Sun Safety Roadshow This year, we wanted to show our deep appreciation to NIVEA Sun who have supported Cancer Research UK for the last decade. To help us achieve our vision of a world where everyone can live longer, better lives, free from the fear

The Free Cancer Hospital, Kensington, London, established 1851. Credit: The Free Cancer Hospital, Kensington, London: aerial view. Wood engraving, 1859. Wellcome Collection. Public Domain Mark Do you know why it’s called cancer? “The first identification of the word cancer is from the Ancient Greeks. They used the term ‘karkinos’, which translates in Latin to canker or cancer

© Anne-Katrin Purkiss Cancer Research UK would like to pay tribute to Dame Valerie Beral, whose research has contributed enormously to the field of women’s health. Dame Valerie was born in Australia where she studied medicine at the University of Sydney. After a few years of clinical work, she turned her attention to epidemiology and

As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience. We caught up with him to find out why these are incredibly exciting times for life sciences, how he’ll represent the voice of the researcher community, and explore the role of curiosity in a goal driven

The changes to our DNA that cause cancer are most often what’s called somatic mutations. Somatic mutations are mutations that affect any of the cells in our body except for the sex cells – the egg or sperm. That means they can’t be passed on to the next generation. These mutations can be caused by

Yesterday, Jo Hargroves from University College London Hospitals NHS Foundation Trust won the ‘Excellence in Cancer Research Nursing Award’ at the Royal College of Nursing’s annual Nursing Awards – the only award in the UK to recognise research nurses working on cancer trials and studies. We hear from Jo and the other shortlisted nurses about

A Talk Cancer workshop interpreted in Urdu that we ran in Middlesborough, in partnership with Nur Fitness. Talking about cancer has the power to save lives. 1 in 2 of us will get cancer in our lifetime, but around 4 in 10 cases of cancer in the UK could be prevented. Equipping people with the

The National Institute for Health and Care Excellence (NICE) has recommended zanubrutinib (Brukinsa) as an option for treating some people with Waldenstrom’s macroglobulinaemia (WM), a rare type of non-Hodgkin lymphoma (NHL) that develops in white blood cells. Zanubrutinib is now the first WM drug NICE has recommended for routine NHS use in England. It is

Over the past 20 years, the use of tobacco has fallen from 1.4 billion to 1.3 billion people , globally. This progress is thanks to the efforts of advocates around the world enacting the policy change needed to protect individuals from tobacco’s harmful effects. We want to ensure that policy changes around tobacco control in

Today, the UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those at high risk of the disease. This has the potential to greatly improve early diagnosis of lung cancer. Screening programmes for breast, cervical and bowel cancer save thousands of lives from cancer each year. Now,

A partnership between Cancer Research UK and Blood Cancer UK has resulted in the UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people. What will this mean for the cancer research community? We spoke to Professor Christina Halsey to find out… The VIVO Biobank provides a

Keith competing in the Red Bull Soapbox Race 2019 at Alexandra Park, London It’s well known that exercise reduces cancer risk by helping people maintain a healthy weight, but can it make any difference for people living with cancer? “Research is showing exercise can be helpful both during and after cancer treatment,” says Martin Ledwick,

Welcome to the fourth post in our Inequalities Series, which discusses health inequalities and how they relate to cancer, from prevention and early diagnosis to treatment and research. In this article, we explore some of the barriers that can make it harder for some people to access cancer screening. We spoke to Dr Laura Marlow,

Today, more than 8 in 10 children and young people in the UK, aged 0 to 24, survive their cancer for 10 years or more. Survival of children and young people has hugely increased over the last 50 years. In fact, progress we’ve made in treating and diagnosing these cancers means that we have avoided

The last couple of weeks has been quite the firestorm for the new Truss administration. When the Prime Minister and the new Government front bench team get past the period of national mourning for the sad passing of the Queen, once-in-a-generation government interventions on the spiralling cost of living and the associated mini-budget, and the

It’s known that people from more deprived backgrounds are more likely to get cancer. New analysis from Cancer Research UK has revealed that ending smoking in England would have the biggest impact on closing the ‘cancer inequality gap’ between the most affluent individuals and the rest of the country. Published today in PLOS ONE, the

The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists… As we mark peer review week – it’s good to take time to reflect on how pivotal the process is in maintaining the quality of research. This year’s theme, Research Integrity: creating and supporting

I think I got the racks as a Christmas present in 2000. I was diagnosed with Hodgkin’s lymphoma the day after Thanksgiving that year, then started chemotherapy soon after (I think three to four days a week). When I put them together, I didn’t know what to think. Will I not live long enough to

Katie Currie (middle) was put on a trial for mitoxantone after she was diagnosed with relapsed ALL. Children’s cancer mortality has almost halved in the UK in the past 3 decades*. But we’ve made more progress in the treatment of some cancers than others. Acute Lymphoblastic Leukaemia (ALL), the most common type of leukaemia diagnosed

The National Institute for Health and Care Excellence (NICE) does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective. This means that people with prostate cancer with a mutation in the BRCA1 or BRCA2 gene that has spread to another part of the body

NurPhoto In 2012, 65% of all cancer deaths globally occurred in low- and middle-income countries (LMICs). This estimate is projected to rise to 75% by 2030. With 44% of these deaths being attributed to preventable risk factors, we have a duty as a world-leading cancer organisation to utilise our knowledge of developing and supporting life-saving

A long-term study funded by Cancer Research UK has revealed how air pollution can cause lung cancer in people who have never smoked. Led by Professor Charles Swanton, our chief clinician, scientists at the Francis Crick Institute and University College London (UCL) have found that exposure to air pollution promotes the growth of cells carrying